Page last updated: 2024-12-05

anthanthrene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Anthanthrene is a polycyclic aromatic hydrocarbon (PAH) with the formula C22H12. It is a yellow crystalline solid that is insoluble in water but soluble in organic solvents. Anthanthrene is a relatively rare compound that is found in coal tar and other fossil fuels. It is also produced as a byproduct of the combustion of organic materials. Anthanthrene has been shown to have carcinogenic properties in laboratory animals. It is also a known mutagen. Anthanthrene is a highly stable molecule, and its unique electronic structure has made it an interesting subject of study for physicists and chemists. Anthanthrene is also being explored for potential applications in organic electronics and materials science.'

Cross-References

ID SourceID
PubMed CID9118
CHEBI ID82389
MeSH IDM0041809

Synonyms (29)

Synonym
dibenzo(cd,jk)pyrene
brn 2052392
dibenzo(def,mno)chrysene
anthranthrene
anthanthren [german]
ccris 48
einecs 205-884-3
anthanthrene
dibenzo[def,mno]chrysene
C19327
dibenzo[cd,jk]pyrene
191-26-4
unii-l65ozg189h
l65ozg189h ,
anthanthren
anthanthrene [iarc]
CHEBI:82389
YFIJJNAKSZUOLT-UHFFFAOYSA-N
dibenz[def,mno]chrysene
DTXSID9075452
anthanthrene, bcr(r) certified reference material
dibenzo[def,mno]chrysene; anthanthren; anthanthrene; dibenzo[cd,jk]pyrene
anthanthrene 10 microg/ml in cyclohexane
anthanthrene 100 microg/ml in acetonitrile
anthanthrene 10 microg/ml in acetonitrile
J-012361
Q2852723
naphtho[7,8,1,2,3-nopqr]tetraphene
hexacyclo[11.7.1.14,20.02,11.03,8.017,21]docosa-1,3(8),4,6,9,11,13,15,17(21),18,20(22)-undecaene

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
ortho- and peri-fused polycyclic arene
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (40.00)18.7374
1990's0 (0.00)18.2507
2000's4 (40.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.09 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]